#USA #Somerville #omics #Matterworks #PyxisLabs

PyxisLabs Revolutionizes Biochemical Omics

In a groundbreaking announcement, PyxisLabs™, an AI-driven laboratory under Matterworks, Inc., has unveiled two new commercial offerings aimed at democratizing access to quantitative biochemical omics. This shift is poised to transform how researchers approach biochemical studies, providing services and licensing options that rival traditional sequencing in terms of cost and turnaround times.

The New Offerings

The two main offerings include a biochemical analysis service and an enterprise subscription license that grants access to Pyxis's innovative analysis capabilities. With the biochemical analysis service priced at $200 per sample, customers can submit samples directly to the laboratory for comprehensive biochemical interpretation. This service includes identification of small molecules and lipids along with quantification, making it extremely valuable for application scientists involved in metabolomics, lipidomics, and exposomics research.

For laboratories that generate their own mass spectrometry data, the enterprise licensing model allows access to Pyxis technology on their own instruments at an approximately $25 per sample subscription cost. With this tiered modular approach, labs can read and interpret their own data while leveraging Pyxis's framework for de novo structure identification and quantitative analysis. A variety of modules are available, starting with those designed for small-molecule and lipid analyses, with a peptide module expected to launch later in 2026.

Bridging the Cost Gap in Biochemical Research

The introduction of these services directly targets the historical cost disparity in biochemical omics versus genomics. Dr. Fadi Abdi, Executive Vice President and Head of PyxisLabs, indicated that this initiative is about breaking down barriers. He stated, "Sequencing scaled the moment that its cost and turnaround stopped being a constraint, and now, biology is set to expand similarly across the biochemical layer."

What's revolutionary about Pyxis’s offerings is the use of Matterworks' Large Spectral Model (LSM), which streamlines the interpretation of mass spectrometry data. By enabling predictions of concentration computationally without needing physical calibration standards for each analyte, Pyxis significantly lowers costs.

One of the key advancements is the ability to provide results quickly, with turnaround times that allow for rapid research applications. This empowers scientists and researchers, providing them with immediate access to the analytical capabilities that were previously available only in high-end labs.

Direct Benefits for Researchers

As biomedical research increasingly seeks to correlate biochemical markers with physiological conditions, having precise and rapid biochemical analysis becomes essential. With Pyxis's intervention, researchers can now focus on experiments and interpretations without worrying about the prohibitive costs previously associated with biochemical analyses.

Dr. Amy Caudy, Vice President of Biochemical Omics at Matterworks, emphasized the practical uses of Pyxis in research endeavors: "Labs can license the modules they need and immediately apply Pyxis to applications such as biomarker discovery, quantitative mechanism of action, target discovery and optimization, or large population studies."

This modular approach means that labs can tailor their use of the technology according to their specific needs. Laboratories that require extra capacity or lack in-house mass spectrometry can simply leverage the Lab Services to benefit from Pyxis’s extensive capabilities.

Conclusion: A New Era for Biochemical Analysis

The unveiling of these services by PyxisLabs represents a monumental advancement in biochemical research, potentially leading to a paradigm shift in how studies are conducted in predictive biology. As access to precise biochemical analysis tools becomes more widespread, it heralds the dawn of a new era where researchers are empowered to explore the biochemical world with as much ease as geneticists have enjoyed with genomics. As this field continues to evolve, PyxisLabs is at the forefront of making biochemical analysis accessible, efficient, and cost-effective for all researchers.

For more details or inquiries, please reach out to PyxisLabs or visit their website to explore how these offerings can enhance your research capabilities.